In addition (Moriyama et al., 2016), suggested that NUDT15 R139C may dephosphorylate the AZA-active metabolites TGTP and TdGTP rather than 6-TGN, which may explain why our concentrations were lower than the established range for IBD. Here, NUDT15 is linked to inflammatory bowel disease.